Physical examination (n = 14)
|
n = 4/5 (80%)
|
n = 2/2 (100%)
|
n = 3/3 (100%)
|
n = 0
|
n = 1/2 (50%)
|
n = 1/1 (100%)
|
n = 11/14 (78%)
|
Organ or mobility dysfunction (n = 15)
|
n = 6/6 (100%)
|
n = 2/2 (100%)
|
n = 4/4 (100%)
|
n = 1/1 (100%)
|
n = 1/1 (100%)
|
n = 1/1 (100%)
|
n = 15/15 (100%)
|
Pain (n = 10)
|
n = 3/3 (100%)
|
n = 1/1 (100%)
|
n = 4/4 (100%)
|
n = 0
|
n = 1/1 (100%)
|
n = 1/1 (100%)
|
n = 10/10 (100%)
|
Bleeding (n = 4)
|
n = 1/1 (100%)
|
n = 0
|
n = 1/1 (100%)
|
n = 1/1 (100%)
|
n = 1/1 (100%)
|
n = 0
|
n = 4/4 (100%)
|
Oozing (n = 4)
|
n = 1/1 (100%)
|
n = 1/1 (100%)
|
n = 0
|
n = 0
|
n = 2/2 (100%)
|
n = 0
|
n = 4/4 (100%)
|
Repetitive infections (n = 10)
|
n = 6/6 (100%)
|
n = 2/2 (100%)
|
n = 0
|
n = 0
|
n = 2/2 (100%)
|
n = 0
|
n = 10/10 (100%)
|
Quality of life (n = 16)
|
- No amelioration
|
n = 0
|
n = 0
|
n = 0
|
n = 0
|
n = 0
|
n = 0
|
n = 0 (0%)
|
- Moderate amelioration
|
n = 3/6 (50%)
|
n = 0
|
N = 1/4 (25%)
|
n = 0
|
n = 2/2 (100%)
|
n = 0
|
n = 6/16 (37.5%)
|
- Strong amelioration
|
n = 3/6 (50%)
|
n = 2/2 (100%)
|
n = 3/4 (75%)
|
n = 1/1 (100%)
|
n = 0
|
n = 1/1 (100%)
|
n = 10/16 (62.5%)
|
Reduced coagulopathy (n = 8)
|
n/a
|
n/a
|
n = 4 /4 (100%)
|
n = 1/1 (100%)
|
n = 2 /2 (100%)
|
N = 1/1 (100%)
|
n = 8/8 (100%)
|
MRI (T1,T2 Fat Sat,STIR) (n = 16)
|
- Progression
|
n = 1/6 (17%)
|
n = 1/2 (50%)
|
n = 1/4 (25%)
|
n = 0
|
n = 0
|
n = 0
|
n = 3/16 (19%)
|
- Status quo
|
n = 2/6 (33%)
|
n = 0
|
n = 2/4 (50%)
|
n = 0
|
n = 1/2 (50%)
|
n = 1/1 (100%)
|
n = 6/16 (37%)
|
- Amelioration
|
n = 3/6 (50%)
|
n = 1/2 (50%)
|
n = 1/4 (25%)
|
n = 1/1 (100%)
|
n = 1/2 (50%)
|
n = 0
|
n = 7/16 (44%)
|
ITK-SNAP
3–0
(n = 9)
|
- Volume augmentation
|
n = 0
|
n = 0
|
n = 0
|
n = 0
|
n = 0
|
n = 0
|
n = 0/9 (0%)
|
- No volume modification
|
n = 0
|
n = 0
|
n = 1/4 (25%)
|
n = 0
|
n = 0
|
n = 0
|
n = 1/9 (11%)
|
- Volume reduction
|
n = 2/2 (100%)
|
n = 1/1 (100%)
|
n = 3/4 (75%)
|
n = 1/1 (100%)
|
n = 1/1 (100%)
|
n = 0
|
n = 8/9 (89%)
|